Tempo Scan re-IPO

Tempo Scan share sale increased to $229 million

Robust demand from high-quality institutions allows the majority owner to sell more shares than planned in Tempo Scan, an Indonesian pharmaceutical and consumer products company.

<div style="text-align: left;"> Tempo Scan's $229 million offering is the biggest equity deal in Indonesia this year </div>

May 11, 2012

The controlling shareholder of Indonesia’s Tempo Scan Pacific has raised Rp2.12 trillion ($229 million) from the sale of existing shares through a fully marketed transaction that was enlarged beyond the previously announced deal size, pushing the free-float above 20%.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].